Carroll Bio-Consulting
↗Boston, USA
Carroll Bio-Consulting is the strategic advisory firm of Dr. Pamela Carroll. The firm provides high-level consulting to biotechnology companies, venture capital firms, and academic institutions on drug discovery strategy, business development, and the implementation of emerging technologies like AI and machine learning in R&D.
Through this vehicle, Dr. Carroll serves as a Venture Partner at Aulis Capital and a Strategic Advisor to several stealth and mid-stage biotechs. The firm specializes in bridging the gap between complex biological research and commercial business strategy, particularly in the oncology and platform technology sectors.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Strategic Consulting & Advisory
SIZE & FINANCIALS
Employees:1-50
Revenue:N/A
Founded:2018
Ownership:private
Status:operating
FUNDING
Stage:Self-funded / Professional Services
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, Cell therapy, Vaccines, AI/ML Discovery
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Aulis Capital (Venture Partner), Saint Michael's College (Board of Trustees), Novartis (via Isomorphic Labs advisory), Eli Lilly (via Isomorphic Labs advisory)
COMPETITION
Position:Niche Player
Competitors:Back Bay Life Science Advisors, L.E.K. Consulting (Life Sciences), ClearView Healthcare Partners
LEADERSHIP
Key Executives:
Pamela Carroll, PhD - Principal
Scientific Founders:Pamela Carroll, PhD
Board Members:Pamela Carroll (Board of Trustees, Saint Michael's College)
LINKS
Website:carrollbio.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Carroll Bio-Consulting. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.